These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 4866346)
1. Thiothixene (Navane)--another antipsychotic drug. Med Lett Drugs Ther; 1968 Jan; 10(1):1-2. PubMed ID: 4866346 [No Abstract] [Full Text] [Related]
2. [The clinical picture of action of floropipamide. Results of several years of clinical studies]. Bente D; Flegel H; Katscher H; Pfeiffer W Arzneimittelforschung; 1966 Feb; 16(2):312-4. PubMed ID: 4861660 [No Abstract] [Full Text] [Related]
3. Extended trial of thiothixene in chronic psychotic patients. Bishop MP; Gallant DM; Steele CA Psychiatry Dig; 1968 Aug; 29(8):15-22. PubMed ID: 4875882 [No Abstract] [Full Text] [Related]
4. [Clinical experience with a new neuroleptic (R. 6238)]. Bonhour A; Borel RO Prensa Med Argent; 1971 Aug; 58(24):1265-6. PubMed ID: 4940120 [No Abstract] [Full Text] [Related]
5. [Comparative study of Navane concentrate and tablets]. Radmayr E Wien Z Nervenheilkd Grenzgeb; 1968; 26(4):340-60. PubMed ID: 4241209 [No Abstract] [Full Text] [Related]
6. [Thiothixene (Navane). A new neuroleptic drug]. Jensen PS; Bolwig T; Aalund P Nord Psykiatr Tidsskr; 1969; 23(4):404-11. PubMed ID: 4915880 [No Abstract] [Full Text] [Related]
7. Basic principles of rapid neuroleptization. Mason AS; Granacher RP Dis Nerv Syst; 1976 Oct; 37(10):547-51. PubMed ID: 9267 [No Abstract] [Full Text] [Related]
8. Clinical trial of navane (THIOTHIXENE) in schizophrenia. Simeon J; Keskiner A; Ponce D; Itil T; Fink M Curr Ther Res Clin Exp; 1967 Jan; 9(1):10-6. PubMed ID: 4963017 [No Abstract] [Full Text] [Related]
9. Predictors of therapeutic responsivity to thiothixene in schizophrenics. Sterlin C; Oliveros R; Ban TA Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603 [No Abstract] [Full Text] [Related]
10. Therapy for psychotic and psychoneurotic depression with thiothixene and perphenazine-amitriptyline (a double-blind clinical study). McLaughlin BE Dis Nerv Syst; 1969 Feb; 30(2):Suppl:85-8. PubMed ID: 4886995 [No Abstract] [Full Text] [Related]
11. Efficacy of haloperidol in drug refractory patients. Ban TA; Lehmann HE Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:78-86. PubMed ID: 4383142 [No Abstract] [Full Text] [Related]
12. A preliminary study of Thiothixene in chronic schizophrenics. Simpson GM; Iqbal J Curr Ther Res Clin Exp; 1965 Nov; 7(11):697-700. PubMed ID: 4953690 [No Abstract] [Full Text] [Related]
13. [Psychopharmacological experiences with methophenazine with particular reference to Leonhard's classification of endogenous psychoses]. Neumann J; Schulze HA Psychiatr Neurol Med Psychol (Leipz); 1966 Jan; 18(1):11-7. PubMed ID: 4862323 [No Abstract] [Full Text] [Related]
14. Thiothixene versus trifluoperazine in newly-admitted schizophrenic patients. Bishop MP; Fulmer TE; Gallant DM Curr Ther Res Clin Exp; 1966 Nov; 8(11):509-14. PubMed ID: 4962777 [No Abstract] [Full Text] [Related]
15. [Clinical experiences with thiothixene (navane) in chronic schizophrenia]. Gann G Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801 [No Abstract] [Full Text] [Related]
16. Our experience with octoclothepine therapy. Klíma V; Koutská M; Koutský J Act Nerv Super (Praha); 1972; 14(2):89-90. PubMed ID: 5040175 [No Abstract] [Full Text] [Related]
17. [Long term drug therapy of schizophrenia]. Berzewski H Pharmakotherapia; 1964; 2(1):181-9. PubMed ID: 5875712 [No Abstract] [Full Text] [Related]
18. [Drug treatment of psychoses]. Anttinen EE Suom Laakaril; 1965 May; 20(13):931-6. PubMed ID: 5879961 [No Abstract] [Full Text] [Related]